Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume $4.29 +0.14 (+3.37%) Closing price 04:00 PM EasternExtended Trading$4.08 -0.22 (-5.01%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lixte Biotechnology Short Interest DataLixte Biotechnology (LIXT) has a short interest of 191,100 shares, representing 8.49% of the float (the number of shares available for trading by the public). This marks a 4,146.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 6.31 million shares to cover all short positions.Current Short Interest191,100 sharesPrevious Short Interest4,500 sharesChange Vs. Previous Month+4,146.67%Dollar Volume Sold Short$172.95 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2025Outstanding Shares2,680,000 sharesFloat Size2,250,000 sharesShort Percent of Float8.49%Today's Trading Volume175,102 sharesAverage Trading Volume6,310,397 sharesToday's Volume Vs. Average3% Short Selling Lixte Biotechnology? Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLIXT Short Interest Over TimeLIXT Days to Cover Over TimeLIXT Percentage of Float Shorted Over Time Lixte Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025191,100 shares $172.95 thousand +4,146.7%8.5%0.1 $0.91 6/15/20254,500 shares $5.13 thousand -55.9%0.2%0.1 $1.14 5/31/202510,200 shares $12.04 thousand -68.7%0.5%0.5 $1.18 5/15/202532,600 shares $46.94 thousand +65.5%1.6%1.6 $1.44 4/30/202519,700 shares $24.82 thousand -25.7%1.0%0.3 $1.26 4/15/202526,500 shares $33.63 thousand -11.7%1.4%0.4 $1.27 3/31/202530,000 shares $36.30 thousand -44.0%1.6%0.5 $1.21 3/15/202553,600 shares $64.86 thousand +26.7%2.9%0.8 $1.21 2/28/202542,300 shares $54.99 thousand -23.8%2.3%0.7 $1.30 2/15/202555,500 shares $80.48 thousand -42.2%3.3%0.9 $1.45 Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/31/202596,000 shares $232.32 thousand -14.8%5.4%1.6 $2.42 1/15/2025112,700 shares $276.12 thousand +2.9%6.3%0.2 $2.45 12/31/2024109,500 shares $222.29 thousand -7.1%6.1%0.2 $2.03 12/15/2024117,900 shares $234.04 thousand -13.6%6.6%0.2 $1.99 11/30/2024136,400 shares $304.17 thousand -27.9%7.6%0.2 $2.23 11/15/2024189,100 shares $306.34 thousand -57.8%10.5%0.3 $1.62 10/31/2024448,000 shares $945.28 thousand +2,348.1%24.9%0.7 $2.11 10/15/202418,300 shares $32.94 thousand -26.5%1.0%0.4 $1.80 9/30/202424,900 shares $46.56 thousand -28.0%1.4%0.5 $1.87 9/15/202434,600 shares $68.85 thousand +10.9%1.9%0.7 $1.99 8/31/202431,200 shares $55.54 thousand +225.0%1.7%0.4 $1.78 8/15/20249,600 shares $19.49 thousand +20.0%0.5%0.2 $2.03 7/31/20248,000 shares $17.28 thousand -33.3%0.4%0.2 $2.16 7/15/202412,000 shares $28.92 thousand -25.9%0.7%0.3 $2.41 6/30/202416,200 shares $38.39 thousand -12.9%0.9%0.4 $2.37 6/15/202418,600 shares $45.57 thousand +53.7%1.0%0 $2.45 5/31/202412,100 shares $28.29 thousand -24.8%0.7%0 $2.34 5/15/202416,100 shares $36.87 thousand -31.8%0.9%0 $2.29 4/30/202423,600 shares $68.20 thousand -71.5%1.3%0 $2.89 4/15/202482,700 shares $272.91 thousand +395.2%4.6%0.2 $3.30 3/31/202416,700 shares $56.45 thousand -14.8%1.0%0 $3.38 3/15/202419,600 shares $45.28 thousand -62.3%1.1%0.5 $2.31 2/29/202452,000 shares $135.20 thousand +258.6%3.0%1.4 $2.60 2/15/202414,500 shares $39.44 thousand +42.2%0.8%0.3 $2.72 1/31/202410,200 shares $21.06 thousand +117.0%0.6%0.4 $2.07 1/15/20244,700 shares $9.12 thousand -63.0%0.3%0.1 $1.94 12/31/202312,700 shares $29.85 thousand -32.5%0.7%0.3 $2.35 12/15/202318,800 shares $39.67 thousand -26.0%1.1%0.4 $2.11 11/30/202325,400 shares $59.18 thousand -60.1%1.5%0.5 $2.33 11/15/202363,700 shares $184.73 thousand +295.7%3.7%1.2 $2.90I warned you about Nvidia… now look what’s happening (Ad)Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.Watch how Tim Sykes trades AI headlines for real gains 10/31/202316,100 shares $38.72 thousand -1.8%0.9%0.4 $2.41 10/15/202316,400 shares $39.36 thousand -44.6%1.0%0.3 $2.40 9/30/202329,600 shares $72.52 thousand +261.0%2.1%0.2 $2.45 9/15/20238,200 shares $17.38 thousand +13.9%0.6%0.1 $2.12 8/31/20237,200 shares $18.04 thousand -44.2%0.3%0.1 $2.51 8/15/202312,900 shares $32.25 thousand -84.3%0.6%0.1 $2.50 7/31/202382,200 shares $289.34 thousand +774.5%4.7%0.6 $3.52 7/15/20239,400 shares $51.04 thousand +8.1%1.0%0.1 $5.43 6/30/20238,700 shares $50.72 thousand -28.7%0.5%0.4 $5.83 6/15/202312,200 shares $57.95 thousand +306.7%1.5%0.7 $4.75 5/31/20233,000 shares $20.78 thousand -86.2%0.4%0.3 $6.93 5/15/202321,800 shares $14.48 thousand +162.7%0.3%0.2 $0.66 4/30/20238,300 shares $4.66 thousand -80.0%0.1%0 $0.56 4/15/202341,500 shares $26.15 thousand -45.8%0.5%0 $0.63 3/31/202376,500 shares $63.29 thousand -39.1%1.0%0.1 $0.83 3/15/2023125,700 shares $85.85 thousand +31.5%1.7%0.1 $0.68 2/28/202395,600 shares $86.76 thousand -38.7%1.3%0.1 $0.91 2/15/2023156,000 shares $180.96 thousand +459.1%2.1%0.1 $1.16 1/31/202327,900 shares $22.04 thousand -62.6%0.4%0 $0.79 1/15/202374,500 shares $42.47 thousand +89.1%1.0%2 $0.57 12/30/202239,400 shares $20.05 thousand -7.9%0.5%1.2 $0.51 12/15/202242,800 shares $23.17 thousand -15.9%0.6%1.7 $0.54 11/30/202250,900 shares $38.94 thousand +53.3%0.7%1.8 $0.77 11/15/202233,200 shares $18.28 thousand +26.7%0.5%1.1 $0.55 10/31/202226,200 shares $13.11 thousand +5.2%0.4%0.5 $0.50 10/15/202224,900 shares $12.98 thousand -58.5%0.4%0.2 $0.52 9/30/202260,000 shares $33.61 thousand +64.4%0.9%0.5 $0.56 9/15/202236,500 shares $25.76 thousand -43.4%0.5%0.3 $0.71 8/31/202264,500 shares $50.31 thousand -30.0%0.9%0.5 $0.78 8/15/202292,100 shares $74.58 thousand +435.5%1.3%0.6 $0.81 7/31/202217,200 shares $12.93 thousand -27.4%0.2%0.1 $0.75 7/15/202223,700 shares $19.43 thousand +0.9%0.3%0 $0.82 6/30/202223,500 shares $17.50 thousand -20.3%0.3%0 $0.74 6/15/202229,500 shares $21.54 thousand -38.3%0.4%0 $0.73 5/31/202247,800 shares $35.87 thousand -12.3%0.7%0 $0.75 5/15/202254,500 shares $51.82 thousand -59.9%0.8%0 $0.95 4/30/2022136,000 shares $160.48 thousand -92.4%2.7%0 $1.18 4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57 3/31/202216,800 shares $20.66 thousand +8.4%0.4%0.1 $1.23 3/15/202215,500 shares $17.05 thousand -59.2%0.3%0 $1.10 2/28/202238,000 shares $53.96 thousand -9.5%0.7%0 $1.42 2/15/202242,000 shares $68.46 thousand -66.0%0.7%0 $1.63 1/31/2022123,600 shares $239.78 thousand -62.3%2.2%0.1 $1.94 1/15/2022328,200 shares $643.27 thousand +589.5%5.8%0.2 $1.96 12/31/202147,600 shares $56.64 thousand +14.2%0.8%0 $1.19 12/15/202141,700 shares $57.96 thousand +110.6%0.7%0.8 $1.39 11/30/202119,800 shares $32.27 thousand -54.2%0.4%0.4 $1.63 11/15/202143,200 shares $78.19 thousand -20.2%0.8%0.9 $1.81 10/29/202154,100 shares $101.71 thousand +0.4%1.0%0.7 $1.88 10/15/202153,900 shares $100.79 thousand +11.4%1.0%0.1 $1.87I warned you about Nvidia… now look what’s happening (Ad)Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.Watch how Tim Sykes trades AI headlines for real gains 9/30/202148,400 shares $100.67 thousand +25.4%0.9%0.1 $2.08 9/15/202138,600 shares $84.15 thousand +196.9%0.7%0.1 $2.18 8/31/202113,000 shares $31.98 thousand -80.7%0.2%0 $2.46 8/13/202167,400 shares $150.98 thousand +2,006.3%1.2%0.2 $2.24 7/30/20213,200 shares $8.80 thousand -82.4%0.1%0 $2.75 7/15/202118,200 shares $54.42 thousand -37.5%0.3%0.1 $2.99 6/30/202129,100 shares $88.17 thousand +193.9%0.5%0.1 $3.03 6/15/20219,900 shares $29.30 thousand -66.9%0.2%0 $2.96 5/28/202129,900 shares $81.93 thousand +81.2%0.5%0.1 $2.74 5/14/202116,500 shares $42.82 thousand -45.7%0.3%0 $2.60 4/30/202130,400 shares $87.86 thousand +98.7%0.5%0 $2.89 4/15/202115,300 shares $45.44 thousand -62.7%0.3%0 $2.97 3/31/202141,000 shares $132.02 thousand +151.5%1.0%0 $3.22 3/15/202116,300 shares $71.23 thousand -13.8%0.4%0 $4.37 2/26/202118,900 shares $71.25 thousand +575.0%0.5%0 $3.77 2/12/20212,800 shares $10.22 thousand +64.7%0.1%0 $3.65 1/29/20211,700 shares $5.35 thousand -15.0%0.1%0 $3.15 1/15/20212,000 shares $6.52 thousand No Change0.1%0 $3.26 11/15/20208,400 shares $9.49 thousand +140.0%N/A2.8 $1.13 10/30/20203,500 shares $3.92 thousand +2.9%N/A3.9 $1.12 10/15/20203,400 shares $3.91 thousand +17.2%N/A2.1 $1.15 9/30/20202,900 shares $3.39 thousand +107.1%N/A1.4 $1.17 9/15/20201,400 shares $1.40 thousand +40.0%N/A0.1 $1.00 8/31/20201,000 shares $1.18 thousand -9.1%N/A0.3 $1.18 8/14/20201,100 shares $1.30 thousand +37.5%N/A0.7 $1.18 7/31/2020800 shares $952.00 -84.0%N/A0.1 $1.19 LIXT Short Interest - Frequently Asked Questions What is Lixte Biotechnology's current short interest? Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 191,100 shares of LIXT short. 8.49% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest. What is a good short interest percentage for Lixte Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.49% of Lixte Biotechnology's floating shares are currently sold short. Is Lixte Biotechnology's short interest increasing or decreasing? Lixte Biotechnology saw a increase in short interest in June. As of June 30th, there was short interest totaling 191,100 shares, an increase of 4,146.7% from the previous total of 4,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lixte Biotechnology's float size? Lixte Biotechnology currently has issued a total of 2,680,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 2,250,000 shares. How does Lixte Biotechnology's short interest compare to its competitors? 8.49% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lixte Biotechnology: Telomir Pharmaceuticals, Inc. (8.41%), Coeptis Therapeutics Holdings, Inc. (1.62%), Hyperion DeFi, Inc. (4.05%), Kezar Life Sciences, Inc. (3.94%), CalciMedica Inc. (1.68%), Estrella Immunopharma, Inc. (2.08%), SCYNEXIS, Inc. (1.63%), FibroGen, Inc (4.56%), Clene Inc. (4.51%), Sonnet BioTherapeutics Holdings, Inc. (1.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Lixte Biotechnology stock? Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. LIXT shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lixte Biotechnology? A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further. How often is Lixte Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies TELO Short Interest Data COEP Short Interest Data HYPD Short Interest Data KZR Short Interest Data CALC Short Interest Data ESLA Short Interest Data SCYX Short Interest Data FGEN Short Interest Data CLNN Short Interest Data SONN Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIXT) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
